Healthcare

Image

Europe Women’s Health Diagnostics Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • May 2022
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Women’s Health Diagnostics Market, by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy and Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), Tests (Biopsies, Other Breast Cancer Tests, Pregnancy and Fertility Testing, Lab-based Testing, Pregnancy Testing and Ovulation Prediction Kits, Fertility Monitors, Prenatal Genetic Screening and Carrier Testing, CF Testing, Down’s Syndrome and Edwards’ Syndrome Testing, TORCH Testing, Other Prenatal Genetic Disease Tests, Infectious Disease Testing, MRSA Testing, UTI Testing, Hepatitis Testing), and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) – Industry Trends and Forecast to 2029

Europe Women’s Health Diagnostics  Market

Market Analysis and Size

According to the World Health Organization, over 470 million women live in the European Region, accounting for just over half of the total population. Understanding the demographic and epidemiological changes occurring in this diverse Region, like as ageing and migration, requires an understanding of women's health. Furthermore, the GDP of the European Union region was around USD 18.8 trillion in 2018, according to the World Bank, and health spending is the second largest item of general government spending after social security spending. Total health spending by the federal government was 9.6 percent of GDP. This will increase healthcare infrastructure and the number of clinical laboratories and diagnostic facilities in Europe, boosting the market for women's health diagnostics in the coming year.

Data Bridge Market Research analyses that the  women’s health diagnostics market which was USD 26.48 billion in 2021, would rocket up to USD 41.88 billion by 2029, and is expected to undergo a CAGR of 5.9% during the forecast period 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Women's health refers to the diagnosis and treatment of illnesses and diseases that may affect a woman's physical and mental well-being. Women's health includes birth control, sexually transmitted infections (STIs), gynaecology disorders, breast cancer, ovarian cancer, other female cancers, menopause, hormone therapy, osteoporosis, pregnancy and childbirth, sexual health, women and heart disease, and benign conditions affecting the function of the female reproductive organs.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy and Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe

Market Players Covered

Siemens (Germany), Hologic, Inc. (MA), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (NJ), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp.(U.S.A), Shimadzu Medical (India) pvt. Ltd. (Japan), GENERAL ELECTRIC (U.S.), Quest Diagnostics Incorporated (U.S.), Sysmex India Pvt. Ltd. (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (U.K)

Market Opportunities

  •  Rising prevalence in research and development spending
  • Rising development of miniature diagnostic devices

Women’s Health Diagnostics Market Dynamics

Drivers

  • Increasing incidence of chronic and lifestyle-related disorders

The expanding number of imaging and diagnostic centres, as well as the expanded usage of point-of-care and fast diagnostic tests. As the prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer rises, the market for women's health diagnostics is growing. Breast cancer is the most frequent cancer in women and the second-most-common cancer in the globe. In 2018, nearly 2 million new cases were reported.

  • Increase in the rate of approval of point-of-care diagnostic testing

The market is expected to grow as the number of diagnostic and imaging machines sold around the world rises. However, a surge in demand for the development of miniature diagnostic devices, as well as an increase in healthcare infrastructure and new marketing initiatives by key vendors in emerging countries, are expected to provide market expansion during the forecast period of 2022-2029.

  • Increasing prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer

 Breast cancer is the most frequent cancer in women and the second-most-common cancer in the globe. According to Globocan 2020, 2,261,419 new cases of breast cancer will be diagnosed in 2020. The rising number of cases has resulted in increased sales of test kits for home use, which is expected to fuel the market's revenue growth throughout the forecast period. Increased acceptance of point-of-care diagnostic testing and an increase in the number of diagnostic and imaging equipment available globally are expected to drive the market forward.

Opportunities

Breast cancer's rising prevalence, greater research and development spending, and improvements in cancer diagnostics are all expected to accelerate segmental expansion. According to Globocan, roughly 2.26 million new instances of breast cancer were diagnosed in females worldwide in 2020, accounting for around 11.7 percent of all cancer cases. As the patient pool for breast cancer develops, demand for diagnostics is projected to climb even quicker. Product launches are another major factor in the market's expansion.

Restraints/Challenges

Patients' resistance to early screening, which needs considerable expenditures for detection, the possibility of over-diagnosis and overtreatment, and the fact that MRI scans are accurate yet time consuming and costly for patients are all problems that the women's health diagnostic market faces.

Diagnostic tests for women's health are costly, which is a significant barrier to market entry. The women's health diagnostic sector has considerable challenges due to a lack of information about various illnesses and diagnostic methodologies. Low-income companies and emerging economies are addressing market constraints in women's health diagnostics.

This  women’s health diagnostics  market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women’s health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Women’s Health Diagnostics Market

Due to capital market and global economy uncertainty, limited transit options and travel restrictions created impediments to international trade and transportation during the COVID-19 pandemic, affecting the supply chain for women's health diagnostics and temporarily lowering demand. The advancement of this industry is impeded by unfavourable changes in rules and laws. According to major regulatory organisations, COVID-19 infection is more common in breast cancer patients than in healthy people. Screening, surgical operations, and diagnostic screenings at hospitals and breast cancer clinics have all been postponed or severely curtailed as a result.

Recent Development

  • Roche announced in May 2019 that the VENTANA HER2 Dual ISH DNA Probe Cocktail assay for detecting the HER2 biomarker in gastric and breast cancer would be available. This would contribute to the company's product line being expanded.

Europe Women’s Health Diagnostics Market Scope

The women’s health diagnostics market is segmented on the basis of test, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

  • Osteoporosis Testing
  • Bone Densitometry
  • In Vitro Blood Tests
  • OVC Testing
  • OVC Tumor Marker Tests
  • OVC Diagnostic Imaging Tests
  • Other OVC Tests
  • Cervical Cancer Testing
  • Pap Smears
  • HPV Testing
  • Breast Cancer Testing
  • Mammography

Tests

  • Biopsies
  • Other Breast Cancer Tests
  • Pregnancy and Fertility Testing
  • Lab-based Testing
  • Pregnancy Testing and Ovulation Prediction Kits
  • Fertility Monitors
  • Prenatal Genetic Screening and Carrier Testing
  • CF Testing
  • Down’s Syndrome and Edwards’ Syndrome Testing
  • TORCH Testing
  • Other Prenatal Genetic Disease Tests
  • Infectious Disease Testing
  • MRSA Testing
  • UTI Testing
  • Hepatitis Testing
    • Tuberculosis Testing
    • Other Infectious Disease Tests
    • STD Testing
    • CT/NG Testing
    • HIV Testing
    • Other STD Tests
    • Ultrasound Tests
    • Breast Imaging
    • OB/GYN Imaging

End-User

  • Hospitals and Clinics
  • Diagnostic and Imaging Centers
  • Home Care Settings

 Women’s Health Diagnostics Market Regional Analysis/Insights

The women’s health diagnostics market is analysed and market size insights and trends are provided by country, test, application and end user as referenced above.

The countries covered in the  women’s health diagnostics  market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The high prevalence of cancer among women, the rising incidence of lifestyle-related disorders, the high adoption of technologically advanced products, product launches, and government initiatives, the women's health diagnostic market in North America and Europe is expected to grow steadily.

By increasing campaigns on women's health issues and disease awareness, the Asia-Pacific region has improved its healthcare situation and has emerged as a growing participant in the women's health diagnostic market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The women’s health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for women’s health diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the women’s health diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and Women’s Health Diagnostics Market Share Analysis

The women’s health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to women’s health diagnostics market.

Some of the major players operating in the women’s health diagnostics market are:

  • Siemens (Germany)
  • Hologic, Inc. (MA)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Abbott (U.S.)
  • BD (NJ)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • NeuroLogica Corp.(U.S.A)
  • Shimadzu Medical (India) pvt. Ltd. (Japan)
  • GENERAL ELECTRIC (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • Sysmex India Pvt. Ltd. (Japan)
  • Hitachi, Ltd. (Japan)
  • Canon Inc. (Japan)
  • FUJIFILM Holdings Corporation (U.K)


SKU-

TABLE 1 RESEARCH AND DEVELOPMENT (USD MILLION)

TABLE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 3 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 5 EUROPE MAMMOGRAPHY SYSTEMS DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE, 2017-2026 (USD MILLION)

TABLE 6 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)

TABLE 7 EUROPE ULTRASOUND IMAGING SYSTEMS DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)

TABLE 8 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)

TABLE 9 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)

TABLE 10 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)

TABLE 11 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)

TABLE 12 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 13 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 14 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 15 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 16 EUROPE BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 18 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 19 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 20 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE REAGENTS AND KITS IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 22 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 23 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 24 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 25 EUROPE BIOMARKERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 27 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 28 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 30 EUROPE HOSPITALS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 EUROPE DIAGNOSTIC AND IMAGING CENTERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE CLINICS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 EUROPE HOME CARE SETTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 35 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 36 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 37 EUROPE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 38 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 39 EUROPE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 40 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 41 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 42 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 43 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 44 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 45 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 46 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 47 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 48 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 49 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 50 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 51 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 52 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 53 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 54 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 55 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 56 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 57 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 58 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 59 GERMANY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 60 GERMANY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 61 GERMANY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 62 GERMANY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 63 GERMANY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 64 GERMANY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 65 GERMANY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 66 GERMANY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 67 GERMANY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 68 GERMANY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 69 GERMANY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 70 GERMANY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 71 GERMANY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 72 GERMANY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 73 GERMANY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 74 GERMANY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 75 GERMANY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 76 GERMANY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 77 GERMANY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 78 GERMANY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 79 GERMANY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 80 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 81 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 82 FRANCE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 83 FRANCE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 84 FRANCE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 85 FRANCE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 86 FRANCE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 87 FRANCE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 88 FRANCE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 89 FRANCE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 90 FRANCE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 91 FRANCE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 92 FRANCE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 93 FRANCE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 94 FRANCE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 95 FRANCE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 96 FRANCE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 97 FRANCE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 98 FRANCE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 99 FRANCE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 100 FRANCE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 101 FRANCE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 102 FRANCE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 103 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 104 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 105 U.K. IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 106 U.K. MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 107 U.K. APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 108 U.K. ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 109 U.K. APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 110 U.K. PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 111 U.K. PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 112 U.K. OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 113 U.K. APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 114 U.K. APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 115 U.K. APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 116 U.K. BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 117 U.K. BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 118 U.K. BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 119 U.K. BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 120 U.K. BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 121 U.K. ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 122 U.K. REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 123 U.K. PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 124 U.K. BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 125 U.K. STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 126 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 127 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 128 ITALY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 129 ITALY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 130 ITALY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 131 ITALY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 132 ITALY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 133 ITALY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 134 ITALY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 135 ITALY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 136 ITALY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 137 ITALY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 138 ITALY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 139 ITALY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 140 ITALY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 141 ITALY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 142 ITALY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 143 ITALY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 144 ITALY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 145 ITALY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 146 ITALY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 147 ITALY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 148 ITALY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 149 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 150 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 151 SPAIN IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 152 SPAIN MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 153 SPAIN APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 154 SPAIN ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 155 SPAIN APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 156 SPAIN PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 157 SPAIN PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 158 SPAIN OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 159 SPAIN APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 160 SPAIN APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 161 SPAIN APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 162 SPAIN BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 163 SPAIN BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 164 SPAIN BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 165 SPAIN BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 166 SPAIN BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 167 SPAIN ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 168 SPAIN REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 169 SPAIN PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 170 SPAIN BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 171 SPAIN STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 172 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 173 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 174 RUSSIA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 175 RUSSIA MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 176 RUSSIA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 177 RUSSIA ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 178 RUSSIA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 179 RUSSIA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 180 RUSSIA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 181 RUSSIA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 182 RUSSIA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 183 RUSSIA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 184 RUSSIA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 185 RUSSIA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 186 RUSSIA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 187 RUSSIA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 188 RUSSIA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 189 RUSSIA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 190 RUSSIA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 191 RUSSIA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 192 RUSSIA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 193 RUSSIA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 194 RUSSIA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 195 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 196 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 197 SWITZERLAND IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 198 SWITZERLAND MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 199 SWITZERLAND APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 200 SWITZERLAND ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 201 SWITZERLAND APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 202 SWITZERLAND PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 203 SWITZERLAND PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 204 SWITZERLAND OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 205 SWITZERLAND APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 206 SWITZERLAND APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 207 SWITZERLAND APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 208 SWITZERLAND BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 209 SWITZERLAND BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 210 SWITZERLAND BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 211 SWITZERLAND BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 212 SWITZERLAND BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 213 SWITZERLAND ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 214 SWITZERLAND REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 215 SWITZERLAND PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 216 SWITZERLAND BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 217 SWITZERLAND STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 218 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 219 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 220 NETHERLANDS IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 221 NETHERLANDS MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 222 NETHERLANDS APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 223 NETHERLANDS ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 224 NETHERLANDS APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 225 NETHERLANDS PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 226 NETHERLANDS PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 227 NETHERLANDS OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 228 NETHERLANDS APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 229 NETHERLANDS APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 230 NETHERLANDS APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 231 NETHERLANDS BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 232 NETHERLANDS BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 233 NETHERLANDS BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 234 NETHERLANDS BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 235 NETHERLANDS BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 236 NETHERLANDS ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 237 NETHERLANDS REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 238 NETHERLANDS PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 239 NETHERLANDS BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 240 NETHERLANDS STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 241 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 242 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 243 BELGIUM IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 244 BELGIUM MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 245 BELGIUM APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 246 BELGIUM ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 247 BELGIUM APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 248 BELGIUM PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 249 BELGIUM PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 250 BELGIUM OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 251 BELGIUM APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 252 BELGIUM APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 253 BELGIUM APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 254 BELGIUM BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 255 BELGIUM BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 256 BELGIUM BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 257 BELGIUM BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 258 BELGIUM BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 259 BELGIUM ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 260 BELGIUM REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 261 BELGIUM PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 262 BELGIUM BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 263 BELGIUM STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 264 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION

TABLE 265 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 266 TURKEY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 267 TURKEY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 268 TURKEY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 269 TURKEY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 270 TURKEY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 271 TURKEY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 272 TURKEY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 273 TURKEY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 274 TURKEY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 275 TURKEY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 276 TURKEY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 277 TURKEY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 278 TURKEY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 279 TURKEY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 280 TURKEY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 281 TURKEY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)\

TABLE 282 TURKEY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 283 TURKEY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 284 TURKEY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 285 TURKEY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 286 TURKEY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 287 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 288 REST OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Europe Women’s Health Diagnostics Market value is expected USD 41.88 billion by 2029.
The Europe Women’s Health Diagnostics Market is projected to grow at a CAGR of 5.9% during the forecast period of 2022-2029.
On the basis of application, the Europe Women’s Health Diagnostics Market is segmented into (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy and Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others.
The major players operating in the Europe Women’s Health Diagnostics Market are Siemens (Germany), Hologic, Inc. (MA), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (NJ), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp.(U.S.A), Shimadzu Medical (India) pvt. Ltd. (Japan), GENERAL ELECTRIC (U.S.), Quest Diagnostics Incorporated (U.S.), Sysmex India Pvt. Ltd. (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (U.K).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials